CRTH2 antagonists in asthma: current perspectives
Clinical Pharmacology: Advances and Applications · 2017-12 · Volume 9 · 165-173
DOI: 10.2147/cpaa.s119295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2017-12. Verfasst von Dave Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection, Immunity and Respiratory Medicine, The Medicines Evaluation Unit, Manchester Academic Health Science Centre, Manchester Univer…. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infection, Immunity and Respiratory Medicine, The Medicines Evaluation Unit, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, U…
Zitieren
APA
Singh, D., Ravi, A., & Southworth, T. (2017). CRTH2 antagonists in asthma: current perspectives. Clinical Pharmacology: Advances and Applications, Volume 9, 165-173. https://doi.org/10.2147/cpaa.s119295
Vancouver
Singh D, Ravi A, Southworth T. CRTH2 antagonists in asthma: current perspectives. Clinical Pharmacology: Advances and Applications. 2017;Volume 9:165-173. doi:10.2147/cpaa.s119295
BibTeX
@article{Singh2017,
author = {Singh, Dave and Ravi, Arjun and Southworth, Thomas},
title = {CRTH2 antagonists in asthma: current perspectives},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2017},
volume = {Volume 9},
pages = {165--173},
doi = {10.2147/cpaa.s119295}
}
EUVIMED